Advertisement
"Our new name reflects health, life and passion, as well as our commitmentto becoming a leading provider of high-value diagnostics tests that helpphysicians diagnose, select appropriate treatments and improve outcomes forpatients," said Gail S. Page, President and CEO of Vermillion, Inc.
Advertisement
No change of stockholder certificates is required and all currentcertificates in the name of Ciphergen Biosystems will remain valid for futuretransfers.
About Vermillion, Inc.
Vermillion, Inc. (formerly Ciphergen Biosystems, Inc.) is dedicated to thediscovery, development and commercialization of novel high-value diagnostictests that help physicians diagnose, treat and improve outcomes for patients.Vermillion, along with its prestigious scientific collaborators, has ongoingdiagnostic programs in oncology/hematology, cardiology and women's health withan initial focus in ovarian cancer. Based in Fremont, California, moreinformation about Vermillion can be found on the Web athttp://www.vermillion.com.
Forward-Looking Statements
This press release contains "forward-looking" statements regardingVermillion (formerly Ciphergen), including statements with respect to theanticipated closing of the private placement. Any statements contained in thispress release that are not historical facts may be deemed to be forward-looking statements. The words "will," "expected," "intends" or similarexpressions are intended to identify forward-looking statements. There are anumber of important factors that could cause Vermillion's results to differmaterially from those indicated by these forward- looking statements,including risks associated with the satisfaction of the conditions to theclosing of the private placement, as well as other risks detailed from time totime in Vermillion's SEC reports, including its Quarterly Report on Form 10-Qfor the quarter ended June 30, 2007. Vermillion does not undertake anyobligation to update forward-looking statements. You are encouraged to readVermillion's reports filed with the U.S. Securities and Exchange Commission,available at http://www.sec.gov.
SOURCE Vermillion, Inc.
